Colchicine inhibits pressure-induced tumor cell implantation within surgical wounds and enhances tumor-free survival in mice

• Published in: The Journal of clinical investigation 2008-09, Vol.118 (9), p.3170-3180
• Main Authors: Craig, David H, Owen, Cheri R, Conway, William C, Walsh, Mary F, Downey, Christina, Basson, Marc D
• Format: Article
• Language: English
• Subjects: Animals; Biomedical research; Cancer cells; Cell adhesion & migration; Cell Line, Tumor; Colchicine; Colchicine - pharmacology; Colorectal cancer; Disease-Free Survival; Dosage and administration; Focal Adhesion Protein-Tyrosine Kinases - metabolism; Metastasis; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental - drug therapy; Neoplasms, Experimental - mortality; Paxillin - metabolism; Phosphorylation; Physiological aspects; Polymerization; Pressure; Proto-Oncogene Proteins c-akt - metabolism; src-Family Kinases - metabolism; Tubulin Modulators - pharmacology; Tumors; Wound Healing - drug effects
• ISSN: 0021-9738; 1558-8238
• DOI: 10.1172/JCI34279

Iatrogenic tumor cell implantation within surgical wounds can compromise curative cancer surgery. Adhesion of cancer cells, in particular colon cancer cells, is stimulated by exposure to increased extracellular pressure through a cytoskeleton-dependent signaling mechanism requiring FAK, Src, Akt, and paxillin. Mechanical stimuli during tumor resection may therefore negatively impact patient outcome. We hypothesized that perioperative administration of colchicine, which prevents microtubule polymerization, could disrupt pressure-stimulated tumor cell adhesion to surgical wounds and enhance tumor-free survival. Ex vivo treatment of Co26 and Co51 colon cancer cells with colchicine inhibited pressure-stimulated cell adhesion to murine surgical wounds and blocked pressure-induced FAK and Akt phosphorylation. Surgical wound contamination with pressure-activated Co26 and Co51 cells significantly reduced tumor-free survival compared with contamination with tumor cells under ambient pressure. Mice treated with pressure-activated Co26 and Co51 cells from tumors preoperatively treated with colchicine in vivo displayed reduced surgical site implantation and significantly increased tumor-free survival compared with mice exposed to pressure-activated cells from tumors not pretreated with colchicine. Our data suggest that pressure activation of malignant cells promotes tumor development and impairs tumor-free survival and that perioperative colchicine administration or similar interventions may inhibit this effect.